You searched for metabolic diseases - Page 35 of 62

More News! 4 Jan 2018

Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies

…multiple sclerosis and other myelin-related diseases. Rewind will use the money to move its first small molecule product to the clinic and to expand its pipeline. Multiple sclerosis is caused…

January 4, 2018 - 2 minutesmins - By Alex Dale

News and Trends 8 Jan 2020

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

…diseases in the future. “Rare diseases remain an area of significant unmet medical need, where our team’s proven track record and entrepreneurial mindset will enable us to have a positive…

January 8, 2020 - 2 minutesmins - By Helen Albert

News and Trends 15 May 2017

German Biotech Clears Phase I with New Gene Therapy for Glaucoma

…(DME). “We are now moving towards Phase II development in advanced glaucoma but also other TGF-β2 associated diseases such as wet Age-related Macular Degeneration (AMD) and other TGFβ2-associated diseases such…

May 15, 2017 - 2 minutesmins - By Melanie De Almeida

lupus autoimmune disease neutrophil citryll

News and Trends 26 Oct 2022

Partnership for better understanding of Sjögren’s syndrome announced by Evotec

…expand Evotec’s E.MPD database into autoimmune diseases. The conventional symptomatic description of many diseases stands in the way of both diagnosis and effective treatment. “By leveraging PanOmics data, we are…

October 26, 2022 - 3 minutesmins - By Liza Laws

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

…blood-brain barrier. Neurodegenerative diseases are a hot topic, with age-related diseases like Alzheimer’s and Parkinson’s rising in prevalence. In the US alone, 5 million people suffer from Alzheimer’s disease, 1…

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 28 Apr 2020

Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition

…mitochondrial diseases. Through the acquisition, Astellas gains access to Nanna’s drug discovery technology, which focuses on drugs that target the mitochondria, the energy-producing machinery in human cells. In addition to…

April 28, 2020 - 3 minutesmins - By David Kirk

In Depth 24 Jan 2025

Why are there only 20 cell and gene therapies in Europe?

…has historically accepted only incremental premiums on incremental innovation, and only if there is robust comparative data. Because of that, insisting on gene therapies for diseases where patients have an…

January 24, 2025 - 9 minutesmins - By Jules Adam

News and Trends 15 Oct 2020

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

…so the medical need is high,” commented Chord Therapeutics’ CEO, Tom Plitz. “Although rare diseases affect only a small proportion of the overall population, these patients affected by rare diseases…

October 15, 2020 - 3 minutesmins - By Helen Albert

News and Trends 16 Dec 2022

Providence Therapeutics’ mRNA rabies vaccine hits milestone

…Providence’s clinically validated mRNA technology platform. “We are pleased to demonstrate that Providence’s mRNA technology supports development of additional products that fight a number of infectious diseases,” said Brad Sorenson,…

December 16, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 30 Jun 2023

Five biotech companies making a name for themselves in Vancouver

…organ functions to treat diseases; essentially printing materials to be introduced into the human body. The Vancouver-based biotech company has its initial focus on type 1 diabetes and liver diseases….

June 30, 2023 - 6 minutesmins - By Willow Shah-Neville

Dr. Grégoire Stik, group leader at the Josep Carreras Leukaemia Research Institute and co-author of the study.

News and Trends 11 Jul 2023

Immune memory research could lead to next generation of epigenetic drugs

…memory cells, allowing for a fast activation of these cells. These features are altered in chronic inflammation diseases like asthma and could be important in autoimmune diseases and cancer. The…

July 11, 2023 - 3 minutesmins - By Jim Cornall

In Depth 17 Apr 2024

Small but mighty: The role of small-molecule drugs in disease treatment

…to treat a range of different indications. In this article, we explore the field of small-molecule drugs, including what they are, their advantages and disadvantages, and which diseases they can…

April 17, 2024 - 8 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

German Biotech Clears Phase I with New Gene Therapy for Glaucoma

Partnership for better understanding of Sjögren’s syndrome announced by Evotec

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition

Why are there only 20 cell and gene therapies in Europe?

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

Providence Therapeutics’ mRNA rabies vaccine hits milestone

Five biotech companies making a name for themselves in Vancouver

Immune memory research could lead to next generation of epigenetic drugs

Small but mighty: The role of small-molecule drugs in disease treatment

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!